1. |
董力,石应康,邓承祺,等.应用国际标准比值监测心脏机械瓣膜替换术后抗凝治疗.中华胸心血管外科杂志,1999,15 (3):41-43.
|
2. |
Gan GG,Teh Alan,Goh KY,et al.Racial background is a determinant factor in the maintenance dosage of warfarin.Int J Hematol,2003,78 (1):84-86.
|
3. |
Ouirke W,Cahill M,Perera K,et al.Warfarin prevalence,indications for use and haemorrhagic events.Ir Med J,2007,100 (3):402-404.
|
4. |
于景荣,马腾云.华法林的临床应用.吉林医学,2008,10 (20):1811-1812.
|
5. |
董力,石应康,田子朴,等.心脏机械瓣膜替换术后低强度抗凝治疗.中华外科杂志,2003,1 (4):250-252.
|
6. |
Van Nooten GJ,Van Belleghem Y,Caes F,et al.Lower-intensity anticoagulation for mechanical heart valves:a new concept with the ATS bileaflet aortic valve.J Heart Valve Dis,2003,12 (4):495-502.
|
7. |
张远超,喻莉,陈宝钧.华法林在心脏机械瓣膜置换术后抗凝治疗疗效观察.中华实用诊断与治疗杂志,2008,22 (11):858-859.
|
8. |
Geno A,Turp A G,Steidl L,et al.Comparison of a daily fixed 2.5 mg warfarin dose with a 5mg international normalized ratio adjusted,warfarin dose initially following heart valve replacement.Am J Cardiol,2001,88 (1):40.
|
9. |
殷君太,朱家麟,王志农,等.心瓣膜置换术后血浆华法林浓度的动态变化及其临床意义.中国胸心血管外科临床杂志,1999,6 (4):239-241.
|
10. |
Zhou XM,Zhuang W,Hu JG,et al.Lower-Dose anticoagulation in Chinese patients with mechanical heart valves.Asian Cardiovasc Thorac Ann,2005,12 (4):341-344.
|
11. |
孟旭,李金钟,刘岩,等.人工机械瓣膜置换术后口服抗凝药的抗凝治疗强度标准.中华心血管病杂志,2004,32 (7):618-621.
|
12. |
何小平,秦太昌,王志斌.心脏瓣膜置换术后服用华法林抗凝治疗的临床观察.中西医结合心脑血管病杂志,2010,8 (5):616-617.
|
13. |
徐志云,张宝仁,朱家麟,等.国产侧倾碟瓣二尖瓣替换10年以上随访.中华胸心血管外科杂志,1995,11 (3):135-137,190.
|
14. |
Choi JB,Park HK,Kim KH,et al.Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after the maze procedure.Korean J Thorac Cardiovasc Surg,2013,46 (2):117-123.
|
15. |
Nakamura T,Izutani H,Sawa Y.Mid-term outcomes of the modified Cox-maze procedure for elderly patients:a risk analysis for failure.Interact Cardiovasc Thorac Surg,2011,12 (6):924-928.
|